Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients
Open Access
- 7 November 2014
- journal article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 14 (1), 823
- https://doi.org/10.1186/1471-2407-14-823
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- HER2 status in gastric cancers: a retrospective analysis from four Chinese representative clinical centers and assessment of its prognostic significanceAnnals Of Oncology, 2013
- Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in ChinaJournal of Translational Medicine, 2013
- HER2/neutesting for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancerJournal of Clinical Pathology, 2012
- HER2 expression and its clinicopathological features in resectable gastric cancerGastric Cancer, 2012
- HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the LiteratureJournal of Cancer, 2012
- Impact of HER-2 Overexpression/Amplification on the Prognosis of Gastric Cancer Patients Undergoing Resection: A Single-Center Study of 1,036 PatientsThe Oncologist, 2011
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarrayJournal of Clinical Pathology, 2006
- Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the WorldJournal of Clinical Oncology, 2006
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987